反义AKT2 RNA抑制U251胶质瘤细胞生长的体内外研究

目的 研究反义AKT2RNA对U251人脑胶质瘤细胞在体内外的生长抑制效用。方法 将逆转录病毒pLXSN为载体的反义AKT2构建体转染U251人脑胶质瘤细胞系，应用蛋白印记确定基因转染前后AKT2的表达水平。流式细胞法与Matrigel基质生长实验评价肿瘤细胞转染前后的增殖活性。进一步应用裸鼠皮下荷瘤模型观察脂质体介导pLXSN、pLXSN-AS-AKT2基因治疗对U251细胞生长抑制作用。在28d的观察期内定期测量皮下肿瘤体积，对肿瘤标本应用免疫组化的方法进行AKT2和胶质纤维酸性蛋白（GFAP）表达比较。结果 脂质体介导pLXSN-AS-AKT2可显著抑制U251细胞AKT2表达。与对照组和pLXSN转染组比较，细胞周期分析结果表明AK—AKT2转染组进入S期的细胞数减少了8．5％～8．9％，而进入G0＋G1期细胞则增加了7．9％～8．6％。Matrigel基质生长实验显示对照组和pLXSN转染组细胞呈正常形态贴壁生长，而AS～AKT2转染组细胞不能贴壁生长，呈团块状簇集生长。裸鼠皮下荷瘤模型实验显示pLXSN-AS-AKT2显著抑制皮下肿瘤生长，组织病理学分析显示AS-AKT2转染组AKT2表达下降而GFAP表达上调。结论 体内外实验证明反义AKT2方法在抗胶质瘤增殖方面作用重要，AKT2可作为基因治疗胶质瘤的优选靶标。     

大鼠骨髓间充质干细胞静脉移植对脊髓损伤的修复作用

目的初步探讨骨髓间充质干细胞（BMSCs）静脉移植对脊髓损伤后神经功能恢复和神经修复的影响。方法体外培养BMSCs，改良Allen法制备大鼠脊髓损伤模型，经尾静脉移植Brdu标记的BMSCs，损伤后24h、移植后1、3、5周评价实验动物的神经功能状况，并检测BMSCs在体内迁移、存活以及分化情况，电子显微镜观察组织形态学变化。结果移植的BMSCs在宿主损伤脊髓中聚集并存活，3～5周后有部分移植细胞表达神经元特异性烯醇化酶（NSE）、神经丝蛋白（NF）、微管相关蛋白（MAP2）；BMSCs静脉移植组大鼠运动功能改善，BBB评分高于对照组（P〈0．05）；5周后组织学观察，与对照组相比移植组损伤区脊髓结构较完整。结论BMSCs经静脉移植后可向脊髓损伤处聚集并存活分化，促进神经修复及神经功能的恢复。     

补肾抗衰口服液对大鼠衰老模型免疫器官影响的实验研究

研究补肾抗衰口服液对大鼠衰老模型免疫器官胸腺和脾脏的影响.结果显示,模型组大鼠胸腺和脾脏重量减轻,胸腺重/体重比值、脾重/体重比值减小,胸腺组织学观察,显示萎缩改变;药物组大鼠胸腺和脾脏重量、胸腺重/体重、脾重/体重比值接近正常对照组,胸腺组织学观察,未显示萎缩改变.本研究结果表明,补肾抗衰口服液能延缓胸腺和脾脏萎缩,保护机体的正常免疫功能,提示该药有抗衰老的作用.     

两种MRI序列对听神经瘤成象的比较与评价

为选择中等场强的ＭＲＩ听神经瘤成像最佳序列。收集手术和病理证实的听神经瘤１３５例，分析序列Ⅰ、Ⅱ对内听道中心层面、三叉神经显示率及ＭＲ征象的显示情况。结果：序列Ｉ择内听道中心层面及三叉神经的显示均优于序列Ⅱ，序列Ⅱ在显示肿瘤内囊变、出血、不肿优于序列Ｉ；对肿瘤钙化、肿瘤血管、脑干移位的观察，两者相仿。结果显示：序列Ｉ在中等场经下作为听神经瘤成像的首选序列，并中运用到小脑角区ＭＲＩ成像。     

Point Mutation in the Parkin Gene on Patients with Parkinson''''s Disease

Summary;To investigate the distribution of possible novel mutations from parkin gene in variant sub-set of patients with Parkinson’s disease(PD)in China and explore whether parkin gene plays an im-portant role in the pathogenesis of PD,70 patients were divided into early-onset group and late-onsetgroup; 70 healthy subjects were included as controls.Genomic DNA from 70 normal controls andfrom those of PD patients were extracted from peripheral blood leukocytes by using standard proce-dures.Mutations of parkin gene(exon 1—12)in all the subjects were screened by PCR-single strandconformation polymorphism(SSCP),and further sequencing was performed in tue samples with ab-normal SSCP results,in order to confirm the mutation and its location.A new missense mutationGly284Arg in a patient and 3 abnormal bands in SSCP electrophoresis from samples of another 3 pa-tients were found.All the DNA variants were sourced from the samples of the patients with early-on-set PD.It was concluded that Parkin point mutation a     

寰枢椎椎弓根钉固定治疗伸直型齿状突骨折合并寰枢关节半脱位

Objective To explore the clinical outcome of atlantoaxial pedicle screw instrument in treatment of extension-type odontoid fracture combined with aflantoaxial subluxation. Methods From December 2002 to December 2006, seven patients with extension-type odontoid fracture combined with at-lantoaxial subluxation were reduced and fixed with atlantoaxial pedicle screw instrument of Vertex system under general anesthesia. There were five males and two females, at mean age of 39.2 years (range 21-59 years). All odontoid fractures were fresh type Aderson Ⅱ. JOA scores of spinal core function was 8.6-14.9 (average 10.7) preoperatively. The X-ray examination, CT scanning and skull traction were performed in all patients preoperatively. Results There found no severe complications such as injuries of vertebral artery, nerve root and spinal cord postoperatively. All patients obtained complete reduction and healing of the fracture and dislocation. The mean off-bed time was four days (3-6 days) after opera-tion. A follow-up for 12-36 months (average 22 months) in all patients showed that the clinical symptom was improved significantly six months postoperatively and that all screws were in proper position verified by X-ray and CT scanning. All patients obtained solid bony union on radiographs, with no loosing or breakage of instrument. The postoperative JOA scores was 13.5-16.9 (average 15.8). Conclusions Allantoaxial pedicle screw fixation has advantages of intraoperative reduction, reliable fixation and high fusion rate and can be used as an effective method for extension-type odontoid fracture combined with at-lantoaxial subluxation.     

新生儿颅内出血的CT诊断（附80例报告）

目的：探讨新生儿颅内出血的CT表现。方法；对1998年5月至2003年5月因难产、窒息、早产的新生儿进行头颅CT检查。结果；蛛网膜下腔出血(SAH)62例；脑实质出血(ICH)5例；硬膜下出血(SDH)15例；脑室内出血5例；混合型出血12例。结论：新生儿颅内出血的CT表现具有一定的特征性；CT对颅内出血的诊断具有重要价值。     

膀胱癌组织P-gp,GST-π和TOPO-Ⅱ表达评估灌注化疗

目的：探讨膀胱癌的多药耐药性(MDR)，指导灌注化疗用药。方法：采用免疫组化法检测44例膀胱癌病理标本中P-糖蛋白(P-gp)、谷胱肽S转移酶(GST-π)和拓扑异构酶(TOPO—Ⅱ)的表达，评估肿瘤耐药谱。结果：①P-gp检测显示，54．5％的病例对阿毒索、丝裂毒索、长春新碱等抗生索类和生物碱类抗癌药高耐药。②GST-π检测显示仅34．1％的病例对顺铂、环磷酰胺等高耐药，而反有56．8％的病例对该类药无耐药或低度耐药。③TOPO-Ⅱ检测显示对阿霉索、柔红毒索、VP16等TOPO-Ⅱ抑制剂类抗癌药，仅13．6％的病例高度耐药，29．5％中度耐药。56．8％低度耐药。结论：检测膀胱癌MDR，了解多药耐药谱，可指导灌注化疗用药。     

医源性子宫内膜异位症的治疗进展

医源性子宫内膜异位症是指由于医学检查或治疗的影响而使子宫内膜异位种植，存活或已有的内膜异位灶进一步发展，近年发病率逐渐上升，原因主要与各种妇产科操作的增多有关，现就医源性子宫内膜异位症的治疗进展作一综述。     

131Ⅰ治疗Graves病剂量探讨

目的　探讨1 31 Ⅰ治疗Graves病时 ,不同的剂量计算方法与治愈率以及治疗后并发症的关系。方法　在计算治疗Graves病所需1 31 Ⅰ时 ,分别采取不同的两种计算方法 ,观察两者治愈率及并发症的发生情况 ,并做多因素对比分析。结果　治疗组较对照组 1次治愈率提高约 12 % ,近期甲状腺功能减退延续为永久性甲状腺功能减退者亦明显减少 ,治疗效果明显优于后者。结论　1 31 Ⅰ治疗剂量计算时 ,既要有公式的规范性 ,又要有根据具体情况调节的灵活性 ,即可明显提高治疗效果